Home
Contact
Targeted therapy
Home
Targeted therapy
Filter by
Categories
Tags
Authors
Show all
All
Editorials
New Trials
Ongoing Trials
Trial Results
All
Anal cancer
Breast cancer
Caregiving
Chemotherapy
Chronic lymphocytic leukemia
COVID-19
De-escalation
Esophagus cancer
GI cancer
Head and neck cancer
HER2+ breast cancer
Hormone therapy
Immune system therapy
Immunotherapy
In memory
Kidney cancer
Late Effects
Leukemia
Lymphoma
Mammography
Mantle cell lymphoma
Melanoma
MRI
Neuropathy
Pancreatic cancer
Pancreatic cysts
Personalized medicine
Personalized screening
Precision medicine
Prevention
Prostate cancer
Renal cell carcinoma
Screening
Side effects
Squamous cell carcinoma
Surveillance
Survivorship
Targeted therapy
Throat cancer
Triple-negative breast cancer
Tumor test
All
Akshay Hanikhindi
Diane Dragaud
ecogacrinnews2
Katie Heller
wpengine
October 14, 2019
October 14, 2019
Categories
Trial Results
Trial Results: With E1912, there is a new standard of care for the initial treatment of patients with chronic lymphocytic leukemia
The combination of ibrutinib plus rituximab was superior to standard treatment for CLL patients age 70 and younger.
February 9, 2020
February 9, 2020
Categories
New Trials
Now Enrolling: Trial EA4181 is comparing three different chemotherapy treatments for newly diagnosed mantle cell lymphoma
Right now, researchers do not know the ideal treatment for people with newly diagnosed mantle cell lymphoma.
February 12, 2020
February 12, 2020
Categories
Trial Results
Trial Results: New TAILORx data shows chemotherapy benefit for women at high risk of breast cancer recurrence
The TAILORx trial answers questions about when to use chemotherapy to treat the most common type of breast cancer.